— Know what they know.
Not Investment Advice
Also trades as: MOLN.SW (SIX) · $vol 0M · 0QXX.L (LSE) · $vol 0M · MLLCF (OTC) · $vol 0M

MOLN NASDAQ

Molecular Partners AG
1W: -9.1% 1M: -3.9% 3M: -2.2% YTD: -7.3% 1Y: +5.4% 3Y: -20.2% 5Y: -80.0%
$3.91
+0.00 (+0.00%)
 
Weekly Expected Move ±9.2%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $146.7M mcap · 37M float · 0.012% daily turnover · Short 25% of daily vol

Cash Flow Trends

Operating Cash Flow
-$51M +13.5% ▲
Capital Expenditures
$714K +1.2% ▲
5Y CAGR: -15.8%
Free Cash Flow
-$52M +13.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$19M +646.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$64M$118M-$62M-$54M-$62M
Depreciation & Amort.$3M$2M$2M$2M$2M
Stock-Based Comp.$4M$5M$5M$4M$4M
Change in Working Capital-$35M-$6M-$6M-$4M$1M
Other Non-Cash Items$848K-$753K$1M-$8M$3M
Operating Cash Flow-$91M$119M-$59M-$59M-$51M
— Investing Activities —
Capital Expenditures-$1M-$1M-$808K-$705K-$714K
Acquisitions (Net)$374K$0$0$0$0
Investment Purchases-$89M-$299M-$278M-$240M-$66M
Investment Sales$68M$199M$319M$277M$138M
Other Investing-$304K$494K$4M$4M$2M
Investing Cash Flow-$22M-$101M$45M$40M$73M
— Financing Activities —
Net Debt Issuance-$1M-$1M-$1M-$1M-$1M
Stock Repurchased$0-$631K$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$267K$250K$31K-$2M$0
Financing Cash Flow$51M-$2M-$1M$14M-$1M
Net Change in Cash-$62M$16M-$21M-$3M$19M
Cash End of Period$72M$88M$67M$64M$83M
Free Cash Flow-$92M$117M-$60M-$60M-$52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms